Intelligent Bio Solutions (INBS) Fireside chat summary

Introduction and agenda

• The session introduced the Intelligent Fingerprinting Drug Screening System and provided updates on the FDA 510(k) submission process, recent financial performance, and future plans.

• The agenda included a company overview, product demonstration, FDA process details, and a live Q&A session.

Background and experience of the speaker

• Leadership highlighted experience in commercializing the product internationally, especially in the UK, and lessons learned from scaling the business.

Current industry trends

• Drug screening demand is rising due to increased legalization of substances like cannabis and heightened focus on workplace safety.

• Non-invasive, rapid testing methods are increasingly preferred over traditional urine or saliva tests.